237 related articles for article (PubMed ID: 31030818)
1. Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children.
Walkovich K; Connelly JA
Hematol Oncol Clin North Am; 2019 Jun; 33(3):533-551. PubMed ID: 31030818
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
4. Modern management of phagocyte defects.
Lanini LL; Prader S; Siler U; Reichenbach J
Pediatr Allergy Immunol; 2017 Mar; 28(2):124-134. PubMed ID: 27612320
[TBL] [Abstract][Full Text] [Related]
5. Severe congenital neutropenias.
Skokowa J; Dale DC; Touw IP; Zeidler C; Welte K
Nat Rev Dis Primers; 2017 Jun; 3():17032. PubMed ID: 28593997
[TBL] [Abstract][Full Text] [Related]
6. Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child.
Shoo A; Swai P; Kindole C; Ngailo E; Godfrey E; Massawe E; Warren AJ; Luzzatto L
Br J Haematol; 2022 Mar; 196(5):1271-1274. PubMed ID: 34725814
[No Abstract] [Full Text] [Related]
7. Altered Functions of Neutrophils in Two Chinese Patients With Severe Congenital Neutropenia Type 4 Caused by
Dai R; Lv G; Li W; Tang W; Chen J; Liu Q; Yang L; Zhang M; Tian Z; Zhou L; Yan X; Wang Y; Ding Y; An Y; Zhang Z; Tang X; Zhao X
Front Immunol; 2021; 12():699743. PubMed ID: 34305938
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for severe congenital neutropenia.
Connelly JA; Choi SW; Levine JE
Curr Opin Hematol; 2012 Jan; 19(1):44-51. PubMed ID: 22080845
[TBL] [Abstract][Full Text] [Related]
9. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
[TBL] [Abstract][Full Text] [Related]
10. Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: the 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony-stimulating factor-responsive clonal abnormality.
White C; Chen Z; Raetz E; Pulsipher M; Spangrude GJ; Slayton WB
Acta Paediatr Suppl; 2002; 91(438):120-3. PubMed ID: 12477275
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
[TBL] [Abstract][Full Text] [Related]
12. Ultra-Sensitive
Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Front Immunol; 2019; 10():116. PubMed ID: 30891028
[TBL] [Abstract][Full Text] [Related]
13. Non-myeloablative transplantation for severe congenital neutropenia.
Thachil J; Caswell M; Bolton-Maggs PH; Pizer B; Keenan R
Pediatr Blood Cancer; 2008 Apr; 50(4):920-1. PubMed ID: 17635003
[TBL] [Abstract][Full Text] [Related]
14. Genetics of severe congenital neutropenia as a gateway to personalized therapy.
Donadieu J; Bellanné-Chantelot C
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):658-665. PubMed ID: 36485107
[TBL] [Abstract][Full Text] [Related]
15. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
16. Congenital neutropenia: From lab bench to clinic bedside and back.
Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of patients with isolated neutropenia.
Newburger PE; Dale DC
Semin Hematol; 2013 Jul; 50(3):198-206. PubMed ID: 23953336
[TBL] [Abstract][Full Text] [Related]
18. Management of a Patient With Congenital Biallelic CSF3R Mutation With GM-CSF.
Yilmaz Karapinar D; Özdemir HH; Akinci B; Yaşar AŞ; Siviş ZÖ; Onay H; Özkinay F
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e164-e166. PubMed ID: 30499904
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factors for the management of neutropenia in cancer patients.
Dale DC
Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated
Nasri M; Ritter M; Mir P; Dannenmann B; Aghaallaei N; Amend D; Makaryan V; Xu Y; Fletcher B; Bernhard R; Steiert I; Hahnel K; Berger J; Koch I; Sailer B; Hipp K; Zeidler C; Klimiankou M; Bajoghli B; Dale DC; Welte K; Skokowa J
Haematologica; 2020 Mar; 105(3):598-609. PubMed ID: 31248972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
